Atypical cystic fibrosis: identification in the primary care setting

Area of Science:

• Medical Research
• Genetics
• Pulmonology

Background:

• Atypical cystic fibrosis (CF) is a milder variant of CF, linked to mutations in the cystic fibrosis transmembrane receptor gene.
• Individuals may exhibit mild dysfunction in a single organ system and variable sweat chloride levels, differing from classic CF presentations.
• The diverse and fluctuating nature of symptoms across respiratory, gastrointestinal, endocrine, metabolic, and genitourinary systems can delay diagnosis.

Purpose of the Study:

• To review the diagnostic approaches for patients presenting with atypical cystic fibrosis (CF).
• To highlight key clinical indicators that should prompt consideration of CF in patients with atypical presentations.
• To emphasize the importance of timely diagnosis and ongoing patient education for managing atypical CF.

Main Methods:

• Comprehensive literature search of MEDLINE and EMBASE databases.
• Review of data from Cystic Fibrosis Canada and patient registry reports.
• Synthesis of findings to characterize atypical CF diagnosis and management.

Main Results:

• Atypical CF is characterized by milder symptoms, potentially affecting one organ system with variable sweat chloride levels.
• Clinical signs in the respiratory, gastrointestinal, endocrine, metabolic, and genitourinary systems can indicate atypical CF.
• Patients with atypical CF often experience fewer childhood hospitalizations and may remain undiagnosed into adulthood.

Conclusions:

• Patients with atypical CF generally have longer life expectancies than those with classic CF, but long-term outcomes remain uncertain.
• Patient counseling regarding potential future health issues and comprehensive CF education is vital.
• Education empowers patients to manage symptoms, optimize health, prevent complications, and consider family planning.